Crossmark

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups

Crossref DOI link: https://doi.org/10.1186/s13023-021-01706-7

Published Online: 2021-02-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rintell, David http://orcid.org/0000-0003-2951-5086
Heath, Dena

Braga Mendendez, Florencia

Cross, Elizabeth

Cross, Theodore

Knobel, Vincent

Gagnon, Bruno

Turtle, Cameron

Cohen, Alan

Kalmykov, Edward

Fox, Jonathan
License Information

Text and Data Mining valid from 2021-02-08

Version of Record valid from 2021-02-08
More Information

Article History

Received: 28 July 2020

Accepted: 21 January 2021

First Online: 8 February 2021

Ethics approval and consent to participate

: An application for Institutional Review Board approval was made to the Western Institutional Review Board, who determined that this study was exempt from IRB approval. All participants signed a consent to participate in the focus groups.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below